Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 71 to 80 of 259 resources

  • National Clinical Guidelines for the treatment of HCV in adults
    These Scottish guidelines, updated in January 2016, provide expert guidance to Health Boards, Area Drug and Therapeutics Committees, and treating clinicians on the efficacy of available treatments for hepatitis C. They also act as a clinical reference source for NHS National Procurement to produce rankings on cost-effectiveness. Development of the guidance was a collaboration between Scotland's viral hepatitis clinical leads and MCN co-ordinators network, National Services Scotland, and Healthcare Improvement Scotland.
    Scotland Jan 2017 Other, Strategy & Planning PDF
  • The 2016 Hep-CORE Report: Monitoring the implementation of hepatitis B and C policy recommendations in Europe
    Published by the European Liver Patients Association, this report provides an overview of the progress made in tackling hepatitis B and C across different European countries, on the basis of surveys undertaken with patient organisations.
    Rest of World Jan 2017 Reports & Research PDF
  • HCV Action and PHE hepatitis C roadshow in Manchester: Presentations
    On 13th December 2016, HCV Action and Public Health England (PHE) staged a hepatitis C good practice roadshow in Manchester. The event was designed to showcase and share best practice in the prevention, diagnosis, testing and treatment of hepatitis C, and identify specific issues and potential solutions for tackling hepatitis C in Manchester and the wider north west region.
    UK, England, North West Other, Strategy & Planning PDF
  • Hepatitis C Commissioning Toolkit
    The Hepatitis C Commissioning Toolkit, originally published in September 2013 and most recently updated in September 2018, outlines the importance of effective commissioning in eliminating hepatitis C and sets out key commissioning responsibilities, with the intention of bringing clarity to an often highly fragmented commissioning landscape.
    England Case study, Tools & Templates, Strategy & Planning PDF
  • Drug-related infectious diseases in Europe
    This report provides an update on infectious diseases related to drug use in Europe for the period up to June 2016. It covers the most recent data both on infectious diseases among people who inject drugs in Europe, collected with the European Monitoring Centre for Drugs and Drug Addiction Drug-related infectious diseases (DRID) indicator, and on the responses in the area. It includes highlights and new findings discussed during the DRID indicator’s annual expert meeting, held in Lisbon on 6–8 June 2016.
    Rest of World Reports & Research PDF
  • The lived experience of interferon-free treatments for hepatitis C: A thematic analysis
    This research paper, published in the International Journal of Drug Policy, examines how interferon-free treatments for hepatitis C are being understood and experienced by patients.
    UK Reports & Research PDF
  • Global report on access to hepatitis C treatment - Focus on overcoming barriers
    This is the first-ever global report on treatment access to hepatitis C medicines. The report provides the information that countries and health authorities need to identify the appropriate HCV treatment, and procure it at affordable prices. The report uses the experience of several pioneering countries to demonstrate how barriers to treatment access can be overcome.

    Rest of World Oct 2016 Reports & Research PDF
  • Pathways Coordinator Q&A
    Andy Pearson, The Hepatitis C Trust’s Pathways Coordinator, explains the role and the importance of testing and referral pathways for hepatitis C in substance misuse services.
    UK Other, Training PDF
  • EASL Recommendations on Treatment of Hepatitis C 2016
    These EASL Recommendations on Treatment of Hepatitis C are intended to assist physicians and other healthcare providers, as well as patients and other interested individuals, in the clinical decision-making process by describing the current optimal management of patients with acute and chronic HCV infections. These recommendations apply to therapies that have been approved by the European Medicines Agency and other national European agencies at the time of their publication.
    Rest of World Sep 2016 Other, Reports & Research PDF
  • Hepatitis C Coalition: Report on Operational Delivery Network Visits
    This report, published by the Hepatitis C Coalition, provides an overview of visits undertaken by the Coalition to Operational Delivery Networks (ODNs) across England. It sets out the detailed analysis of findings from meetings with a variety of health professionals across the country, and includes a number of recommendations intended to further improve the effectivesness of the ODNs.
    England Sep 2016 Reports & Research PDF

Pages